Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion

References

• GlaxoSmithKline Prescribing Information. Wellbutrin (bupropion hydrochloride) Tablets. Research Triangle Park, NC: Accessed March 2013 at: https://www.gsksource.com.
   Google Scholar
• Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6:159–166.
   PubMedGoogle Scholar
• Findlay JW, Van Wyck Fleet J, Smith PG, Butz RF, Hinton ML, Blum MR, Schroeder DH. Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. Eur J Clin Pharmacol 1981; 21:127–135.
   PubMed Web of Science ®Google Scholar
• Daviss WB, Perel JM, Birmaher B, Rudolph GR, Melhem I, Axelson DA, Brent DA. Steady-state clinical pharmacokinetics of bupropion extended-release in youths. J Am Acad Child Adolesc Psychiatry 2006; 45:1503–1509.
   PubMed Web of Science ®Google Scholar
• Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med 2004; 27:147–151.
   PubMed Web of Science ®Google Scholar
• Starr P, Klein-Schwartz W, Spiller H, Kern P, Ekleberry SE, Kunkel S. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med 2009; 27:911–915.
   PubMed Web of Science ®Google Scholar
• Schroeder DH. Metabolism and kinetics of bupropion. J Clin Psychiatry 1983; 44:79–81.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Klein C, Meineke I, Sasse J, Zanger UM, Mürdter TE, et al. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Pharmacogenetics 2003; 13:619–626.
   PubMedGoogle Scholar
• Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI, Greenblatt DJ. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 2000;28:1176–1183.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Zhu AZ, Tyndale RF, Dempsey D, Jacob P III. Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state. Pharmacogenet Genomics 2013; 23:135–141.
   PubMed Web of Science ®Google Scholar
• Belson MG, Kelley TR. Bupropion exposures: clinical manifestations and medical outcome. J Emerg Med 2001; 23:223–230.
   Web of Science ®Google Scholar
• Paris PA, Saucier JR. ECG conduction delays associated with massive bupropion overdose. J Toxicol Clin Toxicol 1998; 36:595–598.
   PubMed Web of Science ®Google Scholar
• Shrier M, Diaz JE, Tsarouhas N. Cardiotoxicity associated with bupropion overdose. Ann Emerg Med 2000; 35:100.
   PubMed Web of Science ®Google Scholar
• Preskorn SH. Antidepressant response and plasma concentrations of bupropion. J Clin Psychiatry 1983; 44:137–139.
   PubMed Web of Science ®Google Scholar
• Lung D, Yeh K, Kiang C. Delayed, fatal cardiotoxicity associated with bupropion and citalopram overdose. J Clin Psychopharmacol 2012; 32:431–434.
   PubMed Web of Science ®Google Scholar
• Biswas AK, Zabrocki LA, Mayes KL, Morris-Kukoski CL. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. J Toxicol Clin Toxicol 2003; 41:101–104
   PubMed Web of Science ®Google Scholar
• Druteika D, Zed PJ. Cardiotoxicity following bupropion overdose. Ann Pharmacother 2002; 36:1791–1795.
   PubMed Web of Science ®Google Scholar
• Morazin F, Lumbroso A, Harry P, Blaise M, Turcan A, Montravers P. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol (Phila) 2007; 45:794–797
   PubMed Web of Science ®Google Scholar
• Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother 2003; 37:999–1002.
   PubMed Web of Science ®Google Scholar
• Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: a case series. Med J Aust 2003; 178:61–63.
   PubMed Web of Science ®Google Scholar
• Caillier B, Pilote S, Castonguay A, Patoine D, Ménard-Desrosiers V, Vigneault P, et al. QRS and QT prolongation under bupropion: a unique cardiac electrophysiological profile. Fundam Clin Pharmacol 2012; 26:599–608.
   PubMed Web of Science ®Google Scholar
• Zhu AZ, Cox LS, Nollen N, Faseru B, Okuyemi KS, Ahluwalia JS, et al. CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion. Clin Pharmacol Ther 2012; 92: 771–777.
   PubMed Web of Science ®Google Scholar
• Curry SC, Kashani JS, LoVecchio F, Holubek W. Intraventricular conduction delay after bupropion overdose. J Emerg Med 2005; 29: 299–305.
   PubMed Web of Science ®Google Scholar
• Silverstone PH, Williams R, McMahon L, Fleming R, Fogarty S. Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice. Ann Gen Psychiatry 2008; 7:19.
   PubMedGoogle Scholar
• Olson KR. Activated charcoal for acute poisoning: one toxicologist's journey. J Med Toxicol 2010; 6:190–198.
   PubMedGoogle Scholar